Table 1.
Baseline characteristics of gastric cancer patients
| Characteristic | Cases | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 197 | 72.2 |
| Female | 76 | 27.8 |
| Age (years) | ||
| < 60 | 152 | 55.7 |
| ≥ 60 | 121 | 44.3 |
| Tumor size (cm) | ||
| < 5 | 161 | 59.0 |
| ≥ 5 | 112 | 41.0 |
| Pathological differentiation | ||
| Moderate+Well | 82 | 30.0 |
| Poor | 191 | 70.0 |
| Invasion depth | ||
| T1 + T2 | 89 | 32.6 |
| T3 + T4 | 184 | 67.4 |
| Lymph nodes metastasis | ||
| Negative | 111 | 40.7 |
| Positive | 162 | 59.3 |
| TNM stage | ||
| I | 66 | 24.2 |
| II | 78 | 28.6 |
| III | 129 | 47.2 |
| CEA (ng/ml) | ||
| ≤ 5 | 221 | 81.0 |
| > 5 | 52 | 19.0 |
| CA199 (U/ml) | ||
| ≤ 37 | 226 | 82.8 |
| > 37 | 47 | 17.2 |
| FPR median (range) | 0.0134 (0.0038–0.1258) | |
| FAR median (range) | 0.0760 (0.0261–0.2989) | |
CEA carcinoembryonic antigen; CA199 carbohydrate antigen 199; OS overall survival; FPR fibrinogen-to-prealbumin ratio; FAR fibrinogen-to-albumin ratio